Evidence map›Paper›PMID 39325191›Full record

ArticleArchives of dermatological research2024

"There is a life before and after cancer": experiences of resuming life and unmet care needs in stage I and II melanoma survivors.

N C W Kamminga, J E C Kievits, M Wakkee, S G W van Loon, M C W Joosen, D Verver, K Munte, P W P Plaisier, J A C Rietjens, T E C Nijsten and 1 more

Erratum issuedAbstract read
In one paragraph

Article in Archives of dermatological research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

N C W KammingaDepartment of Dermatology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.ORCID https://orcid.org/0000-0002-8386-2540
J E C KievitsDepartment of Dermatology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.
M WakkeeDepartment of Dermatology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.ORCID https://orcid.org/0000-0001-8578-901X
S G W van LoonDepartment of Dermatology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.ORCID https://orcid.org/0009-0000-2255-4184
M C W JoosenDepartment Tranzo, Tilburg School of Social and Behavioral Sciences, Tilburg University, Tilburg, The Netherlands.ORCID https://orcid.org/0000-0001-5064-7302
D VerverDepartment of Surgery, Franciscus Gasthuis, Rotterdam, The Netherlands.
K MunteDepartment of Dermatology, Maasstad Ziekenhuis, Rotterdam, The Netherlands.ORCID https://orcid.org/0000-0003-3338-0786
P W P PlaisierDepartment of Surgical Oncology, Albert Schweitzer Hospital, Dordrecht, The Netherlands.ORCID https://orcid.org/0009-0006-0501-813X
J A C RietjensDepartment of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.ORCID https://orcid.org/0000-0002-0538-5603
T E C NijstenDepartment of Dermatology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.ORCID https://orcid.org/0000-0001-9940-2875
M LugtenbergDepartment of Dermatology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands. m.lugtenberg@erasmusmc.nl.ORCID https://orcid.org/0000-0002-4117-2154

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although the largest increase in melanoma incidence is observed for localised melanoma, little research has been done on its impact. Despite favourable prognoses and relatively short treatment trajectories, diagnosis and treatment may significantly impact life post-treatment. Therefore, the aim of this study was to gain an in-depth understanding of stage I and II melanoma survivors' experiences resuming life after treatment and their associated survivorship care (SSC) needs. A qualitative focus group study was conducted with 18 stage I or II melanoma survivors, divided over three focus groups with 6 survivors each. Transcripts were analysed through thorough thematic content analysis, using multiple phases of coding. In resuming life, survivors experienced profound initial impacts of disease and treatment, fed by a perceived lack of knowledge and underestimation of melanoma. They faced unexpected physical and emotional effects post-surgery, experiencing mixed feelings from relief to fear and uncertainty. Survivors felt misunderstood, had to adjust their lives, and managed personal and external expectations while experiencing a positive shift in life perspective, leading to a notable difference in life before and after cancer. In terms of SSC needs, survivors stressed the need for tailored information, accessible resources, patient-centered follow-up, and supportive care addressing the total impact of disease and treatment. These findings highlight the importance of improving melanoma awareness and providing holistic SSC not only to advanced, but also to localised melanoma survivors. A tailored survivorship care plan could facilitate access to information and supportive care, helping patients resume their lives.

Indexed as

Cancer SurvivorsFocus GroupsMelanomaQuality of LifeSkin NeoplasmsAdaptation, PsychologicalAdultAgedFemaleHumansMaleMiddle AgedNeoplasm StagingQualitative ResearchSurvivorshipMelanomaMelanoma survivorsQualitative researchSurvivorship care

Identifiers

PMID39325191
PMCPMC11427545

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.